Close Menu

NEW YORK, Aug. 17 (GenomeWeb News) – Sequenom has signed on the University of Tuebingen in Germany as a user of its MassArray gene expression platform, the company said today.

Under the agreement, the Institute of Medical Genetics and the Microarray facility at the university will use the MassArray Quantitative Gene Expression application to validate existing microarray data and for additional research in Parkinson’s disease, Huntington’s disease and cancers.

The institute will also be a reference site for the system, Sequenom said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.